Deerfield, IL, United States of America

Jeffrey D Kent

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Horizon Therapeutics USA, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey D Kent. Retrieved from https://idiyas.com/inventor/jeffrey-d-kent

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jeffrey D. Kent

Introduction

Jeffrey D. Kent is an accomplished inventor based in Deerfield, IL (US). He has made significant contributions to the field of medicine, particularly in the treatment of gout. With a total of 2 patents to his name, Kent's work focuses on innovative therapies that enhance patient outcomes.

Latest Patents

Kent's latest patents include groundbreaking methods for treating gout. One of his notable inventions is titled "Combination Therapies of Prednisone and Uricase Molecules and Uses Thereof." This patent outlines methods for reducing immunogenicity to pegloticase, a PEGylated uricase. The disclosure provides various methods of treating gout in patients, including the co-administration of a PEGylated uricase and methotrexate (MTX). Additionally, it describes methods for prolonging the urate-lowering effect through the same co-administration strategy.

Career Highlights

Jeffrey D. Kent is currently associated with Horizon Therapeutics USA, Inc., where he continues to develop innovative solutions for patients suffering from gout. His expertise and dedication to research have positioned him as a key figure in the pharmaceutical industry.

Collaborations

Kent collaborates with various professionals in his field, including his coworker John Botson. Their combined efforts contribute to the advancement of therapeutic strategies in treating gout.

Conclusion

Jeffrey D. Kent's contributions to the field of medicine through his patents and work at Horizon Therapeutics USA, Inc. highlight his commitment to improving patient care. His innovative approaches in treating gout demonstrate the impact of dedicated research and collaboration in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…